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Abstract. Telemonitoring is emerging as a compelling application of Body Area Networks 
(BANs). We describe two health BAN systems developed respectively by a European and 
an Australian research team and discuss some issues encountered relating to formalization 
of clinical knowledge to support real-time analysis and interpretation of BAN data. Our 
example application is an evidence-based telemonitoring and teletreatment application for 
home-based rehabilitation following myocardial infarction. The proposal is to establish the 
patient’s individual baseline risk profile and, by real-time analysis of BAN data, continually 
re-assess the current risk level in order to give timely personalised feedback. Static and 
dynamic risk factors are derived from the literature. Many sources express evidence 
probabilistically, suggesting a requirement for reasoning with uncertainty; elsewhere 
evidence requires qualitative reasoning: both familiar modes of reasoning in KBSs. 
However even at this knowledge acquisition stage some issues arise concerning how best to 
apply the clinical evidence. 
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1   Introduction 
 
Telemedicine services such as patient monitoring and treatment are emerging as some of 
the most compelling applications of Body Area Network (BAN) technology. We are 
beginning to investigate in what circumstances it is feasible and useful to apply clinical 
decision support technology to the problem of analysis and interpretation of BAN data. In 
this work-in-progress paper we refer to the example of dynamic risk assessment for 
patients undergoing cardiac rehabilitation. The intention is to build on our current mobile 
monitoring systems for cardiac patients and develop a more intelligent, evidence-based 
monitoring and treatment application for home-based rehabilitation following myocardial 
infarction. The idea is that the cardiology team establishes the patient’s individual 
baseline risk profile and equips the patient with a cardiac rehabilitation BAN. This 
extension of the cardio BAN incorporates a set of body worn sensors and transmits the 
captured biosignals to a remote healthcare location. Analysis of biosignals is performed 
locally on the BAN and/or remotely. As well as providing continuous cardiac monitoring, 
as the current systems do, the proposed BAN application will also continually reassess the 
patient’s current risk level, enabling the system and/or a remote clinician to give 
appropriate personalized, timely advice, support and if necessary, intervention. The 
intention is to support secondary prevention by optimizing rehabilitation activities and 
minimizing dynamic risk whilst maintaining vigilance in respect of adverse events or 
trends (the latter being already implemented in the existing cardio BANs). 
In section 2 we introduce the two existing health BAN systems, one from Sydney and 
one from Twente. Each has been prototyped and trialled on different patient groups. In 
section 3 we outline the example application, namely BAN-based support for patients in 
home-based cardiac rehabilitation. This application could be implemented as an additional 
service running on either of the BAN systems. In section 4 we raise some of the issues 
which were encountered in the knowledge acquisition phase.  
 
 
2. Mobile monitoring and treatment systems 
 
First we describe the monitoring systems developed by two research groups. The 
Telemedicine Group at the University of Twente in The Netherlands and the Personal 
Health Monitor Group at the University of Technology, Sydney, are both researching the 
use of Body Area Networks to provide mobile health services to patients and health 
professionals. Both the European BAN and the Australian BAN incorporate a set of body-
worn devices including one or more sensors and a processing and communication 
platform (a mobile phone or PDA). Fig. 1 shows one variant of the European MobiHealth 
BAN [1-4] and Fig. 2 shows the Australian PHM system [5-8].  
 
 
Fig. 1. One variant of the MobiHealth BAN                          Fig. 2. Personal Health Monitor 
 
At Twente the emphasis has always been on telemedicine, ie. using “extraBAN” 
communication between the patient BAN and a remote healthcare organisation or 
clinician. A generic architecture for Body Area Networks (BANs) and a supporting m-
health service platform have been developed, referred to respectively as the MobiHealth 
BAN and MobiHealth MSP. Based on the generic architecture, a series of specialised 
BANs and software applications have been developed for different patient groups from a 
number of specialties including cardiology. Biosignals measured by body worn sensors 
are transmitted to a remote healthcare location where they can be viewed by clinicians. 
Automated or clinician-initiated feedback and treatment completes the (macro) loop for 
BAN-based m-health services. Since 2002 several telemonitoring and teletreatment 
applications for a variety of (chronic and acute) clinical conditions have been trialled on 
different patient groups over the course of a number of collaborative projects (IST 
MobiHealth, IST XMotion, eTEN HealthService24, Freeband Awareness, eTEN Myotel).  
The group at the University of Technology, Sydney, began researching a contrasting 
approach where the original emphasis was on local (micro-loop) processing, offering local 
monitoring and personalised services to patients to support self-care. The PHM has been 
trialled on 70 low-medium risk cardiac patients at the Sydney Royal North Shore Hospital 
(Cardiology Department) in Australia and is currently under commercial development. An 
extensive description and comparison of the two systems can be found in [9]. 
Both systems can be classed as health BANs according to the Twente definition. In 
both systems captured biosignals undergo a series of processes starting with low level 
signal processing and ending with high level clinical analysis and interpretation to various 
levels of abstraction in order, for example, to detect medical emergencies or adverse 
trends. Both systems include detection of cardiac arrhythmias as one of the offered 
clinical applications (the Sydney Personal Heart Monitor and the Twente cardioBAN).  
  The sensors that are currently integrated in the Personal Health Monitor are: ECG, 
weight scale, accelerometer, blood pressure monitor, blood glucose meter, pulse oximeter 
and GPS. The sensors that have been integrated into the MobiHealth BAN to date are: 
electrodes for measuring 3, 4 and 9 channel ECG and surface EMG,  pulse oximeter, 
respiration sensor, temperature sensor and activity sensors (step-counter, 3D 
accelerometer). 
For certain clinical interpretation tasks, such as detecting when certain pre-specified 
thresholds are exceeded, an algorithmic approach suffices. Other interpretation tasks 
require a more sophisticated approach, involving fusion and analysis of data from multiple 
sensors. At a certain point algorithmic approaches may not be appropriate and both 
research groups have come to realize the necessity, in some applications, of adding more 
intelligence including context awareness to the analysis and interpretation of BAN data 
[10-12, 3].  
 
 
3  Example application: cardiac rehabilitation BAN 
 
Participation in cardiac rehabilitation programmes post MI “has been shown to reduce all-
cause mortality and cardiac mortality when compared to usual care” [13]. The vision of 
[14] was to implement continuous risk assessment for this patient group by means of real-
time analysis and interpretation of BAN-captured biosignals together with context data. 
As well as detecting clinical emergencies and trends this extended cardiology BAN would 
estimate the current risk level and give appropriate feedback and encouragement to 
support compliance (eg exercise and medication reminders) to the patient. The advice 
would attempt to minimize risk levels at any one time for example by rescheduling 
exercise not to coincide with elevation of risk levels caused by other factors such as stress. 
The American Heart Association lists the major non-modifiable risk factors for 
cardiovascular disease as: age, gender, heredity (family history, race). These factors play a 
major part in determining an individual patient’s baseline risk. The major modifiable risk 
factors (cigarette smoking, obesity, hypertension, high blood cholesterol, diabetes mellitus 
and physical inactivity) can be influenced by life-style changes and/or medication. 
However the impact of changes in lifestyle will usually be gradual (over weeks or 
months). Risk of mortality by myocardial infarction or coronary heart disease can be 
estimated based on these modifiable and non-modifiable risk factors. Risk is usually 
expressed in terms of percentage of mortality over a 10 year time span [15]. Other so-
called “contributory factors” are stress, alcohol, diet and nutrition, but “their significance 
and prevalence haven't yet been precisely determined” [15]. In addition to the static or 
relatively slowly changing factors, the literature also refers to factors elevating risk in the 
short term. These ‘triggers’ include time of day, physical exertion, weekly and seasonal 
variations, eating a heavy meal, smoking, and “meteorological stress” (ie exposure to 
extreme temperatures). All these triggers may lead to ischaemia, which could be detected 
directly through ST segment changes on the ECG. However we did not find an algorithm 
for detecting ST segment changes that could be implemented on the BAN at present,  
The proposal was to extend the existing cardiology BAN from Sydney (the PHM 
system) and its software in order to monitor, where possible, these short term risk factors 
and dynamically estimate the changing risk for an individual patient. (The proposed 
application could similarly be implemented by extension of the European MobiHealth 
cardio BAN.) The baseline risk would be set and regularly reviewed by the cardiologist 
and the system would calculate the dynamic risk on the basis of sensor data and context 
information and give appropriate feedback. The cardiac rehabilitation BAN proposed in 
[14] would consist of an extension of the PHM system, consisting of a processing 
platform (a mobile phone) which communicates wirelessly with sensors and context 
sources to continuously update the current risk estimate. The sensors would be electrodes 
(to measure ECG and derive heart rate), accelerometer (to detect falls and to measure 
duration and intensity of physical activity), temperature sensor and blood pressure 
monitor. Context sources would include the internal clock of the mobile phone (time of 
day) and calendar (for seasonal variation in risk). For some factors the patient would be 
required to enter data (eg. heavy meal, cigarette). Note: not all dynamic risk factors 
identified can currently be measured using existing sensors or external context sources. 
At Sydney a first selection of static and dynamic risk factors was established following 
a literature search and a first attempt at formalisation of the knowledge was attempted, 
resulting in a model for dynamic risk assessment and an algorithm incorporating a scoring 
system [16]. The concept was to define a personal baseline risk based on the cardiologist’s 
assessment including the particular fixed and voluntary characteristics of the individual 
patient, and then on a moment-by-moment basis to dynamically increment or decrement 
the current risk score according to changing factors known to influence risk in the short 
term. SCORE risk functions [17] were preferred over Framingham [18] since the target 
group are already diagnosed with cardiac disease or have suffered a cardiac event. The 
resulting model can be regarded as a first approximation based on a literature search only, 
still requiring validation by clinical experts. However even at this early stage many issues 
emerged; here we discuss some points arising from the evidence relating to the role of 
exercise during rehabilitation. 
 
 
3.1   Exercise during cardiac rehabilitation 
 
Exercise is a central component in cardiac rehabilitation. The NICE clinical guideline on 
secondary prevention following a myocardial infarction includes as a key priority that 
“Patients should be advised to undertake regular physical activity sufficient to increase 
exercise capacity” and that “Patients should be advised to be physically active for 20–30 
minutes a day to the point of slight breathlessness” [13]. Some health authorities offer a 
hospital-based rehabilitation programme including exercise sessions which are monitored 
closely by clinical staff. According to the definition of phases of comprehensive cardiac 
rehabilitation found in the UK National Service Framework for Coronary Heart Disease, 
(Appendix F of the full guideline [13]), “structured exercise sessions to meet the assessed 
needs of individual patients” are introduced for eligible patients in Phase 3 of 
rehabilitation, four weeks after the acute cardiac event. Since physical exertion itself can 
be a trigger for further cardiac events, the exercise prescription must be adapted to the 
individual patient and carefully monitored. Phase 3 is usually implemented as a hospital 
based outpatient programme. After this phase, exercise and other lifestyle 
recommendations will be made for Phase 4: “long-term maintenance of changed 
behaviour”. Long term regular exercise has been “shown to reduce all-cause and cardiac 
mortality in patients after an MI” [13]. However the guideline notes that “Maintenance of 
these lifestyle changes in patients after an MI has been shown to decline following the end 
of the patient’s participation in coordinated comprehensive cardiac rehabilitation” and 
identifies the key research question: “What encourages the maintenance of regular 
exercise … beyond the period of comprehensive cardiac rehabilitation?”  
We investigate whether a BAN-based monitoring application could provide patients in 
Phase 4 with support in maintaining and optimizing their long term home-based 
rehabilitation by helping to track and minimize dynamic risk levels and by giving 
monitoring and feedback, and encouragement, reassurance and a sense of safety.  
Currently we are examining the complex set of rules in [16] to see if a Clinical Decision 
Support (CDS) approach could offer a better solution than the algorithmic approach.  
 
 
4   Extension with a CDS component 
 
Many of the sources express clinical evidence in terms of probabilities, suggesting a 
requirement for reasoning with uncertainty; in other cases the medical evidence requires 
qualitative reasoning. A KBS/decision support approach would seem to be appropriate 
and address at least some of the issues. The concept is illustrated in Fig. 3. 
 
 
Fig. 3  CDSS with real time biosignal input from Body Area Network 
 
5   Discussion and Conclusions 
 
The preparatory work to date on the cardiac rehabilitation application has been largely 
concerned with the knowledge acquisition phase, involving searches of the medical 
literature including relevant clinical guidelines to provide the base clinical knowledge. 
Knowledge engineering was initially attempted taking an algorithmic approach, by 
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expressing individual risk factors as rules and defining a scoring system. Currently we 
investigate expressing the knowledge in a suitable KR formalism for processing using 
CDSS technology to analyse and interpret BAN data and context data. Some issues we 
encountered are outlined below. 
Degrees of uncertainty.  Probabilistic evidence on some of the risk factors is sometimes 
expressed with large ranges, variance or margins of error. An example is the estimation 
of ventilatory threshold based on HRmax. The threshold is used in one of the rules in [16]. 
At first sight this appears to be a simple question of estimating and applying a threshold. 
Although both ventilatory threshold and HRmax can be measured directly by a cardiac 
stress test, such tests are inadvisable in post-MI patients (indeed this would violate the 
rules in which they are referenced). Therefore an estimate is used in [16] where 
ventilatory threshold is estimated on the basis of HRmax, which is in turn estimated by the 
formula commonly used in exercise physiology of 220 minus age in years. However this 
HRmax formula has been criticised in [18] as being clinically unfounded: “Research since 
1971 has revealed the error in HRmax estimation, and there remains no formula that 
provides acceptable accuracy of HRmax prediction.” A number of alternative formulae are 
reviewed in [18], but the conclusion is that more research is required to establish a more 
accurate method of estimation. Furthermore, the formula for estimating ventilatory 
threshold in relation to HRmax is itself expressed with a wide margin of variability:  “The 
ventilatory threshold corresponds with approximately 85% of HRmax. But this may vary 
between 50% and 90% of HRmax” [16]. The concern is that such high degrees of 
uncertainty or imprecision will multiply up casting doubt on the likelihood of reaching 
useful conclusions.  
Another point is general lack of consensus over risk factors “Risk factors for 
cardiovascular disease have been defined by various groups and experts for decades. 
Unfortunately, the lack of consensus among these groups and the periodic changes in risk 
factor listings have led to confusion among health care professionals” [19]. 
Finally separate items of clinical evidence, often expressed probabilistically, were 
found in the literature but the issue of finding evidence supporting how to combine, 
normalize and weight these separate items however seems to us to be problematic, and the 
weights assigned in [16] were in many cases arbitrary first ‘guesstimates’. We feel the 
need for expert opinion or further evidence in order to combine, normalize, weight and 
tune the knowledge base relating to the different risk factors. 
To summarise this work-in-progress, we pose the general question: in what 
circumstances it is feasible and useful to apply CDSSs in connection with BAN 
monitoring and treatment applications? Further, in the particular case of real-time cardiac 
risk assessment, we ask if the cardiac rehabilitation BAN concept itself is clinically valid, 
useful and achievable given present knowledge and technology. If the concept is valid, we 
see potential for cost efficient delivery of effective cardiac rehabilitation. NHS Lothian’s 
Heart Manual programme has demonstrated that properly planned and managed home-
based cardiac rehabilitation can be as effective as hospital-based rehabilitation 
programmes [21]. Augmenting this with real-time monitoring and feedback systems for 
home use by patients could further enhance such home-based programmes, hence the 
proposed BAN-supported home-based rehabilitation application might have the potential 
not only to support Phase 4 cardiac rehabilitation, but possibly to replace the hospital-
based Phase 3 of current programmes. The application also has potential for monitoring 
health under extreme circumstances, eg. for deep sea divers repairing oil pipe lines, or 
workers at high altitude, athletes in training or military personnel on the battlefield. In 
Twente we also investigate another application of CDSSs using Actor-Agent 
Communities (AAC) based on Bayesian networks.  This study [22] focuses on 
rehabilitation for chronic pain patients. 
If the concept is valid, but (in the cardiac rehabilitation application or other 
applications) insufficient clinical evidence is currently available to support the 
application, an alternative contribution by our technology might be found in data 
aggregation. Data routinely collected from patient health BANs can furnish large 
collections of clinical data with the potential for data mining in order to yield more 
statistically powerful and accurate clinical evidence. Such data aggregation effort however 
requires standards relating to representation of biosignal data and the associated metadata 
needed to compare and interpret them. 
References 
  
[1] V. M. Jones, R. G. A. Bults, D. M. Konstantas, and P. A. M. Vierhout, "Healthcare PANs: Personal Area 
Networks for trauma care and home care," presented at Fourth International Symposium on Wireless 
Personal Multimedia Communications (WPMC), Aalborg, Denmark, 2001. 
[2] Val Jones, Aart van Halteren, Ing Widya, Nikolai Dokovsky, George Koprinkov, Richard Bults, Dimitri 
Konstantas and Rainer Herzog (2006). MobiHealth: Mobile Health Services based on Body Area 
Networks, IN M-Health: Emerging Mobile Health Systems, Robert H. Istepanian, Swamy Laxminarayan, 
Constantinos S. Pattichis, Editors, Springer. pp.219-36. 624 p. ISBN: 0-387-26558-9. 
[3] V.M. Jones, R. Huis in’t Veld, T. Tonis, R.B. Bults, B. van Beijnum, I. Widya, M. Vollenbroek-Hutten,  H. 
Hermens. Biosignal and Context Monitoring: Distributed Multimedia Applications of Body Area Networks 
in Healthcare. Proceedings of the 2008 IEEE 10th Workshop on Multimedia Signal Processing, 
(MMSP2008), 8-10 October 2008, Cairns, Australia, Editors: David Feng, Thomas Sikora, W.C. Siu, Jian 
Zhang, Ling Guan, Jean-Luc Dugelay, Qiang Wu, Wanqing Li, pp. 820-825. IEEE Catalog Number 
CFP08MSP-CDR, ISBN 978-1-4244-2295-1, Library of Congress 2008902132. Copyright © 2008 IEEE. 
[4] MobiHealth, project:  http://www.mobihealth.org/. 
[5] Personal Health Monitor http://www.personalhealthmonitor.net . 
[6] P.Leijdekkers and V. Gay, 'A Self-Test to Detect a Heart Attack Using a Mobile Phone and Wearable 
Sensors', 21st IEEE International Symposium on Computer-Based Medical Systems 2008 pp. 93-98. 
[7] S. Fokkenrood, P.  Leijdekkers and V. Gay, 'Ventricular Tachycardia/Fibrillation Detection Algorithm for 
24/7 Personal Heart Monitoring', ICOST 2007 on Pervasive Computing Perspectives for Quality of Life 
Enhancement, 21-23 June, 2007 Nara, Japan. 
[8] V. Gay and P. Leijdekkers, 'A Health Monitoring System Using Smart Phones and Wearable Sensors', 
Special Issue on 'Smart Sensors in Smart Homes' International Journal of Assistive Robotics and 
Mechatronics (IJARM), Vol. 8, No. 2, 2007. 
[9] V.M. JONES, V. GAY AND P. LEIJDEKKERS, ‘MOBILE HEALTH MONITORING: A COMPARISON OF  
TECHNICAL APPROACHES AND EXPERIENCE IN EUROPE AND AUSTRALIA’, SUBMITTED TO THE 3RD 
INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING TECHNOLOGIES FOR HEALTHCARE 2009, UK, APRIL 
2009. 
[10]  V.M. JONES, H. MEI, T. BROENS, I. WIDYA, AND J. PEUSCHER, CONTEXT AWARE BODY AREA NETWORKS 
FOR TELEMEDICINE, PROCEEDINGS PACIFIC-RIM CONFERENCE ON MULTIMEDIA (PCM) 2007, CITY 
UNIVERSITY OF HONG KONG, HONG KONG, 11-14 DECEMBER 2007. 
[11] Freeband AWARENESS project, http://www.freeband.nl/project.cfm?id=494&language=en. 
[12] MYOTEL  http://www.myotel.eu/  
[13] Cooper A, Skinner J, Nherera L, Feder G, Ritchie G, Kathoria M, Turnbull N, Shaw G, MacDermott K, 
Minhas R, Packham C, Squires H, Thomson D, Timmis A, Walsh J, Williams H, White A. (2007). Clinical 
Guidelines and Evidence Review for Post Myocardial Infarction: Secondary prevention in primary and 
secondary care for patients following a myocardial infarction London: National Collaborating Centre for 
Primary Care and Royal College of General Practitioners. http://www.nice.org.uk/CG048 
[14] V. Gay, P. Leijdekkers and E. Barin, ‘A Mobile Rehabilitation Application for the Remote Monitoring of 
Cardiac Patients after a Heart Attack or a Coronary Bypass Surgery’, Submitted to 2nd ACM International 
Conference on PErvasive Technologies Related to Assistive Environments (PETRA 2009), Greece, June 
2009.  
[15] http://americanheart.org/presenter.jhtml?identifier=500] 
[16]  T. Kobus, ‘Context aware and personalized evaluation of the risk of occurrence of a cardiovascular event’, 
Master thesis University of Twente/University of Technology, Sydney, 2007. 
[17] S Davis and SS Raza Abidi, 2006. Tailoring Cardiovascular Risk Management Educational Interventions: 
A Synergy of SCORE Risk Assessment and Behaviour Change Mode, Proceedings of the 11th 
International Symposium on Health Information Management Reseacrh - iSHIMR 2006.  
[18] WP Castelli, 1984. Epidemiology of Coronary Heart Disease: The Framingham Study, The American 
Journal of Medicine, Volume 76, Issue 2, Part 1, February 1984, pp 4-12. 
[19] Robert A. Robergs and Roberto Landwehr, The surpprising history of the “HRmax=220-age” equation, 
JEPonline, Journal of Exercise Physiology online, Official Journal of The American Society of Exercise 
Physiologists (ASEP), , ISSN 1097-9751, An International Electronic Journal, Volume 5 Number 2 May 
2002,  available at: http://faculty.css.edu/tboone2/asep/May2002JEPonline.html 
[20] Gulanick, Meg, Cofer, Lynn Adam, Coronary Risk Factors: Influences on the Lipid Profile, The Journal of 
Cardiovascular Nursing:Volume 14(2), January 2000, pp 16-28. 
[21] http://www.theheartmanual.com/ 
[22] Zuidinga, H. Clinical Decision Support for Biosignal Analysis and Interpretation. Master Thesis, 
University of Twente, Enschede, 2009. 
